The Regenexx Difference: A Cell Biology Practice with a Lab and Research Program

Regenexx Difference

A few years ago we picked up on a medical publication that seemed to suggest that injecting mesenchymal stem cells through small bore needles may hurt the stem cells. The theory made some sense, because very thin needles might expose the stem cells to significant shear forces and turbulence that may damage the cells. The problem was that large bore needles used to place stem cells in a knee or shoulder tend to hurt patients more than tiny, thin needles. When looking at the publication more closely, it was clear that the authors had performed some strange machinations to try and replicate in the research lab what a medical provider might do in a clinic while injecting stem cells in a joint to manage arthritis. So we re-ran the experiment with very slow injection of cells and a more accurate representation of how stem cells get injected into joints and found no difference with the less painful thin needles. Since we had conflicting data we remained cautious and tended to stay with slightly bigger needles when injecting knees and shoulders. We just brought on a full-time researcher in the lab, so our research bandwidth has increased. As a result, we just re-performed the same experiment as part of another investigation and low and behold we got the same results-the smaller needles don’t hurt the stem cells. The graph above is from that recent experiment and shows stem cell viability (y axis) with differing needle sizes (x-axis) and shows no significant difference or trend toward less viability with smaller needle sizes. Thus, we will now use the smaller needles that our patients tend to like better. This again brings up again the Regenexx difference, we don’t just follow the directions that come in a kit we bought, we perform the basic research to make sure everyone else’s assumptions are accurate.

Learn More About Regenexx® Procedures
Request a digital booklet and more information to learn about alternatives to orthopedic surgery and the Regenexx patient experience.
We do not sell, or share your information to third party vendors. By submitting the form you agree that you've read and consent to our Privacy Policy.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

TO TOP